ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Admi...
Leadership
Ameet Mallik M.B.A., M.S.
CEO & Director
Jose I. Carmona M.B.A.
Chief Financial Officer
Mohamed Zaki M.D., Ph.D.
Chief Medical Officer
Lisa Michelle Kallebo
Corporate Controller & Chief Accounting Officer
David S. Ege Ph.D.
Chief Technical Officer
Nicole Riley
Head of Investor Relations & Corporate Communications
